KR20110026516A - 피임용 자궁내 전달 시스템 - Google Patents

피임용 자궁내 전달 시스템 Download PDF

Info

Publication number
KR20110026516A
KR20110026516A KR1020117002766A KR20117002766A KR20110026516A KR 20110026516 A KR20110026516 A KR 20110026516A KR 1020117002766 A KR1020117002766 A KR 1020117002766A KR 20117002766 A KR20117002766 A KR 20117002766A KR 20110026516 A KR20110026516 A KR 20110026516A
Authority
KR
South Korea
Prior art keywords
progestogen
endometrial
delivery system
therapeutically active
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020117002766A
Other languages
English (en)
Korean (ko)
Inventor
베른드 두에스테르베르그
만자 아홀라
지르키 피흘라야
헤이키 리티카이넨
하리 주카라이넨
사투 클레몰라
테로 파르카띠
Original Assignee
바이에르 쉐링 파르마 오이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40020198&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20110026516(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 바이에르 쉐링 파르마 오이 filed Critical 바이에르 쉐링 파르마 오이
Publication of KR20110026516A publication Critical patent/KR20110026516A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Communication Control (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
KR1020117002766A 2008-07-03 2009-07-01 피임용 자궁내 전달 시스템 Ceased KR20110026516A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08397516A EP2140860A1 (en) 2008-07-03 2008-07-03 An improved method of contraception
EP08397516.9 2008-07-03

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020157033151A Division KR101659530B1 (ko) 2008-07-03 2009-07-01 피임용 자궁내 전달 시스템

Publications (1)

Publication Number Publication Date
KR20110026516A true KR20110026516A (ko) 2011-03-15

Family

ID=40020198

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020117002766A Ceased KR20110026516A (ko) 2008-07-03 2009-07-01 피임용 자궁내 전달 시스템
KR1020157033151A Expired - Fee Related KR101659530B1 (ko) 2008-07-03 2009-07-01 피임용 자궁내 전달 시스템

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020157033151A Expired - Fee Related KR101659530B1 (ko) 2008-07-03 2009-07-01 피임용 자궁내 전달 시스템

Country Status (23)

Country Link
US (3) US20110146693A1 (enExample)
EP (3) EP2140860A1 (enExample)
JP (3) JP2011526609A (enExample)
KR (2) KR20110026516A (enExample)
CN (2) CN103976816A (enExample)
AR (1) AR072544A1 (enExample)
CA (1) CA2730040A1 (enExample)
CL (1) CL2009001490A1 (enExample)
CY (1) CY1120878T1 (enExample)
DK (1) DK2905014T3 (enExample)
ES (1) ES2673154T3 (enExample)
HR (1) HRP20180869T1 (enExample)
HU (1) HUE037520T2 (enExample)
LT (1) LT2905014T (enExample)
PE (1) PE20100057A1 (enExample)
PL (1) PL2905014T3 (enExample)
PT (1) PT2905014T (enExample)
SI (1) SI2905014T1 (enExample)
SM (1) SMT201800295T1 (enExample)
TR (1) TR201807996T4 (enExample)
TW (2) TWI602556B (enExample)
UY (1) UY31957A (enExample)
WO (1) WO2010000943A1 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2494706C2 (ru) 2008-09-17 2013-10-10 Байер Ой Устройство для введения
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
DE202012012713U1 (de) * 2011-03-04 2014-01-23 Arstat, Inc. Intravaginale Arzneimittelabgabevorrichtung
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
RS62297B1 (sr) 2011-11-23 2021-09-30 Therapeuticsmd Inc Prirodne kombinovane hormonske supstitucione formulacije i terapije
AR089765A1 (es) 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
TW201350122A (zh) * 2012-04-23 2013-12-16 Bayer Pharma AG １８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內用途，包含１８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內系統，及其於避孕及婦科治療之用途
USD718435S1 (en) 2012-05-30 2014-11-25 Medicines360 Intrauterine insertion device
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
SE539540C2 (sv) 2013-09-12 2017-10-10 Qpharma Ab Ett läkemedelsavgivningssystem för en eller flera aktiva beståndsdelar
CN105636577A (zh) * 2013-10-18 2016-06-01 拜耳股份有限公司 子宫内递送系统
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
WO2015189853A1 (en) 2014-06-13 2015-12-17 Meril Endo Surgery Private Limited An intrauterine device
TWI730948B (zh) * 2014-12-08 2021-06-21 芬蘭商拜耳股份有限公司 新穎的熱塑性聚胺甲酸酯，彼等材料於製造子宮內系統之ｔ-框架之用途及由此等材料製成之ｔ-框架
LT3247327T (lt) * 2015-01-21 2019-10-10 Bayer Oy Vaisto pateikimo sistema, apimanti nesteroidinį priešuždegiminį (nsaid) ir progestogeninį junginį, ir gamybos būdai
US20180140640A1 (en) 2015-04-22 2018-05-24 Cadens Beheer B.V. Improved contraceptive methods and compositions and devices for use therein
FI3294300T3 (fi) 2015-05-13 2025-03-06 Bayer Oy Pitkävaikutteinen lääkkeenantolaite implantin tai kierukan muodossa, joka käsittää levonorgestreelia ja etinyyliestradiolia
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
CN108430453B (zh) * 2015-12-21 2023-03-17 拜耳股份有限公司 制造药物递送装置的方法和根据该方法制成的药物递送装置
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
GB2555373A (en) * 2016-08-23 2018-05-02 Reproductive Medicine And Gynaecology Associates Ltd Implant
AU201617347S (en) * 2016-12-23 2017-01-23 Jurox Pty Ltd intravaginal device
AU2018340266A1 (en) * 2017-09-27 2020-03-05 Bayer Oy A method for modifying release of a therapeutically active agent from an elastomeric matrix
EP3727361A4 (en) 2017-12-22 2022-01-12 Alyra Biotech Pty Ltd TREATMENT OF PAIN AND/OR PAIN-RELATED SYMPTOMS RELATED TO DYSMENORRHEA
US20200268932A1 (en) * 2019-02-22 2020-08-27 Arsenal Aaa, Llc. Crosslinkable polymer compositions
EP3962489B1 (en) * 2019-02-22 2023-03-22 Elkem Silicones USA Corp. Drug delivery silicone compositon to improve active ingredient elution
KR102260999B1 (ko) * 2019-03-27 2021-06-04 (주)엠케어코리아 난소암 검사용 임플란트 및 이를 포함하는 검사킷 및 이를 이용한 난소암 검사방법
WO2020237325A1 (en) 2019-05-31 2020-12-03 Alyra Biotech Pty Ltd Methods, compositions and devices for treating neuroinflammatory conditions
CN110215447A (zh) * 2019-06-14 2019-09-10 上海市计划生育科学研究所 甲芬那酸在避孕药物中的应用及其制备的杀精避孕药物
WO2021102220A1 (en) 2019-11-21 2021-05-27 Coopersurgical, Inc. Packaging systems for implantable devices and related methods
CN116807727B (zh) * 2023-08-29 2023-11-21 上海宇度医学科技股份有限公司 一种妇产科医师用临床取环器
WO2025106820A1 (en) * 2023-11-16 2025-05-22 University Of South Florida Method of preventing progesterone contraceptive-induced abnormal uterine bleeding (aub)

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880991A (en) * 1969-03-24 1975-04-29 Brook David E Polymeric article for dispensing drugs
US4188951A (en) 1972-08-17 1980-02-19 Alza Corporation Intrauterine system embracing selected copolymeric membranes for administering beneficial agent
US4495934A (en) 1978-07-25 1985-01-29 Shaw Jr Seth T IUD Arrangement
US4284074A (en) * 1978-07-26 1981-08-18 Shaw Jr Seth T IUD Arrangement
AU538963B2 (en) 1979-07-09 1984-09-06 Seth Thomas Shaw Jr. Drug for use with an iud
FR2539027B1 (fr) * 1983-01-07 1987-03-06 Levrier Marc Systeme endo-uterin contraceptif et therapeutique associant cuivre, argent, hormone naturelle et acide iso amino caproique
NL8603216A (nl) * 1986-12-17 1988-07-18 Kurz Karl Heinz Inrichting om in de uterus te plaatsen.
JP2590358B2 (ja) * 1988-03-01 1997-03-12 正雄 五十嵐 子宮内膜症治療用の子宮内又は膣内投与製剤
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
FI94947C (fi) 1994-04-05 1995-11-27 Maillefer Nokia Holding Sovitelma lankamaisia tuotteita puolaavan koneen yhteydessä
FI97944C (fi) 1994-07-05 1997-03-25 Leiras Oy Vaikuttavaa ainetta luovuttava laite
FI97947C (fi) 1994-09-27 1997-03-25 Leiras Oy Menetelmä lääkepreparaatin valmistamiseksi
AU3968597A (en) * 1996-08-02 1998-02-25 Children's Medical Center Corporation Method of regulating the female reproductive system through angiogenesis inhibitors
EP0944382A1 (en) 1996-09-30 1999-09-29 Brigham & Women's Hospital Methods and compounds for treatment of abnormal uterine bleeding
FI103051B (fi) 1997-08-22 1999-04-15 Schering Oy Uusia blokkikopolymeerejä ja niiden valmistus
FI107339B (fi) 1998-06-30 2001-07-13 Leiras Oy Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
US6056976A (en) 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US20050033163A1 (en) 2001-04-24 2005-02-10 Impres Medical, Inc. Intrauterine implant and methods of use
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
WO2002038159A1 (fr) * 2000-11-10 2002-05-16 Mitsubishi Pharma Corporation Medicaments pour l'hyperplasie endometriale
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
JP2003221338A (ja) * 2002-01-29 2003-08-05 Masao Igarashi 子宮腺筋症治療製剤
ATE461681T1 (de) * 2003-04-29 2010-04-15 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
GB0320238D0 (en) * 2003-08-29 2003-10-01 Medical Res Council Treatment of disease
FI123188B (fi) * 2005-04-05 2012-12-14 Bayer Oy Ultraäänellä havaittavissa oleva kohdunsisäinen järjestelmä
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
CN100441156C (zh) * 2006-09-30 2008-12-10 华中科技大学 一种复合材料宫内节育器

Also Published As

Publication number Publication date
EP2313084A1 (en) 2011-04-27
JP6008893B2 (ja) 2016-10-19
US20110146693A1 (en) 2011-06-23
LT2905014T (lt) 2018-07-10
PE20100057A1 (es) 2010-02-25
US20180263899A1 (en) 2018-09-20
ES2673154T3 (es) 2018-06-20
US10532025B2 (en) 2020-01-14
CN103976816A (zh) 2014-08-13
EP2905014A1 (en) 2015-08-12
DK2905014T3 (en) 2018-06-25
CN102088954A (zh) 2011-06-08
UY31957A (es) 2010-01-29
EP2140860A1 (en) 2010-01-06
TWI602556B (zh) 2017-10-21
US20140127280A1 (en) 2014-05-08
JP2014129412A (ja) 2014-07-10
TW201601699A (zh) 2016-01-16
HUE037520T2 (hu) 2018-09-28
SI2905014T1 (en) 2018-08-31
JP2016166245A (ja) 2016-09-15
TR201807996T4 (tr) 2018-06-21
CA2730040A1 (en) 2010-01-07
EP2313084A4 (en) 2014-03-05
EP2905014B1 (en) 2018-04-25
CL2009001490A1 (es) 2010-08-06
WO2010000943A1 (en) 2010-01-07
CY1120878T1 (el) 2019-12-11
HRP20180869T1 (hr) 2018-08-24
US9999592B2 (en) 2018-06-19
JP2011526609A (ja) 2011-10-13
KR101659530B1 (ko) 2016-09-23
TW201002288A (en) 2010-01-16
SMT201800295T1 (it) 2018-07-17
KR20150136143A (ko) 2015-12-04
AR072544A1 (es) 2010-09-08
PL2905014T3 (pl) 2018-10-31
PT2905014T (pt) 2018-06-22

Similar Documents

Publication Publication Date Title
US10532025B2 (en) Intrauterine delivery system for contraception
ES2206865T3 (es) Dispositivo de suministro intravaginal de farmacos.
ES2360806T3 (es) Composiciones de liberación prolongada que contienen moduladores de receptores de progesterona.
ES2337129T3 (es) Sistema de administracion de medicamento comprendiendo un estrogeno tetrahidroxilado para el uso en la anticoncepcion hormonal.
JP2011526609A5 (enExample)
US20160262923A1 (en) Intrauterine delivery system
US20170312219A1 (en) Method of contraception
US20200383906A1 (en) Hormonal contraception using a vaginal ring which releases estriol and trimegestone
HK1157208A (en) An intrauterine delivery system for contraception
HK1197641A (en) An intrauterine delivery system for contraception
HK1221634A1 (zh) 子宫内递送系统

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110201

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20140624

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150619

Patent event code: PE09021S01D

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20151119

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160217

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20150619

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I